Results 131 to 140 of about 71,981 (295)

Clinical and Genetic Characteristics of Parkinson's Disease Patients with Substantia Nigra Hyperechogenicity. [PDF]

open access: yesInt J Mol Sci
Milanowski Ł   +5 more
europepmc   +1 more source

The spatial landscape of glial pathology and T cell response in Parkinson's disease substantia nigra. [PDF]

open access: yesNat Commun
Ma M   +18 more
europepmc   +1 more source

The Discovery of Phages in the Substantia Nigra and Its Implication for Parkinson's Disease. [PDF]

open access: yesResearch (Wash D C)
Zhao Y   +8 more
europepmc   +1 more source

Attention/Working Memory and Executive Function in Parkinson's Disease: Review, Critique, and Recommendations

open access: yesMovement Disorders, EarlyView.
Abstract Background Cognitive impairment in Parkinson's disease (PD) is a well‐established non‐motor complication that significantly affects the quality of life and well‐being of both patients and care partners. To optimally detect mild cognitive impairment or dementia, extensive neuropsychological assessment is essential.
Roberta Biundo   +20 more
wiley   +1 more source

Impaired Glymphatic Clearance, Measured Using Diffusion Tensor Image Analysis Along the Perivascular Space (DTI‐ALPS), is Linked to Poor Cognitive Outcomes in Parkinson's Disease

open access: yesMovement Disorders, EarlyView.
Abstract Background Impaired glymphatic clearance may contribute to pathological accumulations in Parkinson's (PD), but how it interacts with other processes causing dementia remains unclear. Diffusion tensor image analysis along the perivascular space (DTI‐ALPS) has been proposed as an indirect proxy for glymphatic clearance. Objectives To clarify DTI‐
Angeliki Zarkali   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy